Serotonin-related psychedelic drugs

Encyclopedia of Neuroscience

Volumn , Issue , 2009, Pages 731-738

  Geyer, M A ^a   Nichols, D E ^b   Vollenweider, F X ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PURDUE UNIVERSITY   (United States)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Consciousness; Habituation; LSD; Mescaline; Psilocybin; Psychedelics; Psychosis; Schizophrenia; Sensorimotor gating; Serotonin

Indexed keywords

EID: 84882849607     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-008045046-9.01160-8     Document Type: Chapter

References (21)

1. Aghajanian G.K., Marek G.J. Serotonin and hallucinogens. Neuropsychopharmacology 1999, 21:16S-23S.
2. Carter O.L., Burr D.C., Pettigrew J.D., et al. Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors. Journal of Cognitive Neuroscience 2005, 17:1497-1508.
3. Dittrich A. The standardized psychometric assessment of altered states of consciousness (ASCs) in humans. Pharmacopsychiatry 1998, 31:80-84.
4. Fischer R. A cartography of the ecstatic and meditative states. Science 1971, 174:897-904.
5. Geyer M.A. Behavioral studies of hallucinogenic drugs in animals: Implications for schizophrenia research. Pharmacopsychiatry 1998, 31(supplement 2):73-79.
6. Geyer M.A., Callaway C.W. Behavioral pharmacology of ring-substituted amphetamine analogs. Amphetamine and Its Analogs: Neuropsychopharmacology Toxicology and Abuse 1994, 177-208. Academic Press, New York. A.K. Cho, D.S. Segal (Eds.).
7. Geyer M.A., Krebs K.M. Serotonin receptor involvement in an animal model of the acute effects of hallucinogens. NIDA Research Monograph Series: Hallucinogens: An Update 1994, 124-156. US Department of Health and Human Services, Rockville, MD. G. Lin, R.A. Glennon (Eds.).
8. Glennon R.A. Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7). Journal of Medicinal Chemistry 2003, 46:2795-2812.
9. Gouzoulis-Mayfrank E., Habermeyer E., Hermle L., et al. Hallucinogenic drug induced states resemble acute endogenous psychoses: Results of an empirical study. European Psychiatry 1998, 13:399-406.
10. Hofmann A. Psychotomimetic agents. Chemical Constitution and Pharmacodynamic Actions 1968, 169-235. Marcel Dekker, New York. 2nd edn. A. Burger (Ed.).
11. Leuner H. Hallucinogens as an aid in psychotherapy: Basic principles and results. 50 Years of LSD: Current Status and Perspectives of Hallucinogen Research 1994, 175-189. The Parthenon Publishing Group, New York. 1st edn. A. Pletscher, D. Ladewig (Eds.).
12. Mandell A.J., Geyer M.A. The euphorohallucinogens - a study in hemispheric relating. The Comprehensive Textbook of Psychiatry III 1980, 586-599. Williams & Wilkins, Baltimore. A.M. Freedman, H.I. Kaplan, B.J. Sadock (Eds.).
13. Nichols D.E. Role of serotoninergic neurons and 5-HT receptors in the action of hallucinogens. Serotoninergic Neurons and 5-HT Receptors in the CNS 1997, 563-585. Springer, Berlin. H.G. Baumgarten, M. Gothert (Eds.).
14. Nichols D.E. Hallucinogens. Pharmacology & Therapeutics 2004, 101:131-181.
15. Shulgin A., Shulgin A. PIHKAL. A Chemical Love Story 1991, Transform Press, Berkeley.
16. Shulgin A.T., Shulgin A. TIHKAL. The Continuation 1997, Transform Press, Berkeley.
17. Strassman R.J., Qualls C.R., Uhlenhuth E.H., Kellner R. Dose-response study of N, N-dimethyltryptamine in humans. II: Subjective effects and preliminary results of a new rating scale. Archives of General Psychiatry 1994, 51:98-108.
18. Vollenweider F.X., Geyer M.A. A systems model of altered consciousness: Integrating natural and drug-induced psychoses. Brain Research Bulletin 2001, 56:495-507.
19. Vollenweider F.X., Remensberger S., Hell D., Geyer M.A. Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans. Psychopharmacology 1999, 143:365-372.
20. Vollenweider F.X., Vollenweider-Scherpenhuyzen M.F.I., Bäbler A., Vogel H., Hell D. Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. NeuroReport 1998, 9:3897-3902.
21. Vollenweider F.X., Erowid: Documenting the Complex Relationship between Humans and Psychoactives. http://www.erowid.org.